Have a personal or library account? Click to login
Opsoclonus-Myoclonus- Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis Cover

Opsoclonus-Myoclonus- Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis

Tremor and Other Hyperkinetic Movements
Volume 11 (2021): Issue 1
By: Enrique Urrea-Mendoza,  Kimberly Okafor,  Senthuran Ravindran,  John Absher,  Varun Chaubal and  Fredy J. Revilla  
Open Access
|Feb 2021

References

  1. 1Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020; 413: 116832. DOI: 10.1016/j.jns.2020.116832
    Back to article
  2. 2Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019; 12(1). DOI: 10.3390/v12010014
    Back to article
  3. 3Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6): 552–555. DOI: 10.1002/jmv.25728
    Back to article
  4. 4Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020 Oct; 41(10): 2657–2669. Epub 2020 Jul 28. PMID: 32725449; PMCID: PMC7385206. DOI: 10.1007/s10072-020-04575-3
    Back to article
  5. 5Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. Published online April 10, 2020. DOI: 10.1001/jamaneurol.2020.1127
    Back to article
  6. 6Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224): 565–574. DOI: 10.1016/S0140-6736(20)30251-8
    Back to article
  7. 7Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV [published online ahead of print, 2020 Apr 1]. Int J Infect Dis. 2020; 94: 119–124. DOI: 10.1016/j.ijid.2020.03.071
    Back to article
  8. 8Oh SY, Kim JS, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2019; 266(6): 1541–1548. DOI: 10.1007/s00415-018-9138-7
    Back to article
  9. 9Burdick D, Agarwal P. 2016. Myoclonus. In Non–Parkinsonian Movement Disorders (eds D.A. Hall and B.R. Barton). DOI: 10.1002/9781118474075.ch4
    Back to article
  10. 10Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sánchez-Tejerina D, Santos-Fernández T, Folgueira-López MD, Gutiérrez-Gutiérrez J, Ayuso-García B, González de la Aleja J, Benito-León J. Generalized myoclonus in COVID-19. Neurology. 2020 Aug 11; 95(6): e767–e772. Epub 2020 May 21. PMID: 32439821; PMCID: PMC7455360. DOI: 10.1212/WNL.0000000000009829
    Back to article
  11. 11Sanguinetti S, Ramdhani RA. Opsoclonus Myoclonus Ataxia Syndrome Related to the Novel Coronavirus (COVID-19). J Neuroophthalmol. 2020 Sep 7. Epub ahead of print. PMID: 32925477. DOI: 10.1097/WNO.0000000000001129
    Back to article
  12. 12Shah PB, Desai SD. Opsoclonus myoclonus ataxia syndrome (OMAS) in the setting of COVID-19 infection. Neurology. 2020 Oct 1:10.1212/WNL.0000000000010978. Epub ahead of print. PMID: 33004603. DOI: 10.1212/WNL.0000000000010978
    Back to article
  13. 13Chen Y, Chen D, Zhou X, Zhang H, Liao S, Xu Z, Xu P. Opsoclonus-myoclonus syndrome associated with herpes simplex virus infection: a case report. Int J Neurosci. 2020 Mar 9: 1–5. Epub ahead of print. PMID: 32116082. DOI: 10.1080/00207454.2020.1737531
    Back to article
  14. 14Afzal A, Ashraf S, Shamim S. Opsoclonus myoclonus syndrome: an unusual presentation for West Nile virus encephalitis. Proceedings (Baylor University. Medical Center). 2014; 27(2): 108–110. DOI: 10.1080/08998280.2014.11929073
    Back to article
  15. 15Bose K, Saha S, Islam MR, Chakraborty C, Laskar M. Opsoclonus myoclonus ataxia syndrome due to falciparum malaria in two Indian children. Indian J Ophthalmol. 2016 Nov; 64(11): 852–854. PMID: 27958213; PMCID: PMC5200992. DOI: 10.4103/0301-4738.195611
    Back to article
DOI: https://doi.org/10.5334/tohm.580 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 28, 2020
Accepted on: Jan 21, 2021
Published on: Feb 10, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Opsoclonus-Myoclonus Ataxia Syndrome,
SARS-CoV-2,
Movement Disorders,
Postinfection

© 2021 Enrique Urrea-Mendoza, Kimberly Okafor, Senthuran Ravindran, John Absher, Varun Chaubal, Fredy J. Revilla, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 11 (2021): Issue 1Next article